Publications by authors named "James Udelson"

Claim this Profile
E
Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF: Insights From VICTOR.
Faiez Zannad, Yogesh N V Reddy, Irina Barash, Kevin J Anstrom, Marc P Bonaca, James Udelson

J Am Coll Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of a Novel Formulation of Furosemide Administered as a Single Subcutaneous Injection.
Harry Alcorn, John F Mohr, James E Udelson, Barbara W Cornelius, Michael DiBattista

Clin Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Conditions and Patient-Centered Outcomes After Transcatheter Aortic Valve Intervention.
Benjamin S Wessler, Amanda Stebbins, Mohamad Alkhouli, Dharam J Kumbhani, Tsuyoshi Kaneko, James E Udelson

JACC Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of No-Implant Interatrial Shunt for HFpEF: Pooled 12-Month Outcomes From Multicenter Pilot Feasibility Studies.
Brian J Potter, Colin M Barker, Gerard Wilkins, Benjamin Wilkins, Robert Gooley, James E Udelson

JACC Heart Fail· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure.
James E Udelson, Jan Bělohlávek, Andrej Dukát, Justin Ezekowitz, Sorel Goland

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide Trends in Hospitalizations for Sudden Cardiac Arrest Before and During the COVID Outbreak.
Sarah Daoudi, Ariel Furer, Kevin John, Fadi Chalhoub, Jennifer Chee, James Udelson

J Clin Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.
Faiez Zannad, Christopher M O'Connor, Javed Butler, Ciaran J McMullan, Kevin J Anstrom, James Udelson

Lancet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.
Javed Butler, Ciaran J McMullan, Kevin J Anstrom, Irina Barash, Marc P Bonaca, James Udelson

Lancet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial.
Robert J Mentz, Javed Butler, Ciaran J McMullan, Daniel M Wojdyla, Kevin J Anstrom, James Udelson

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial.
Clara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, Aiwen Xing, Davis Gates, James Udelson

Eur J Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre, randomized, double-blind, active and placebo-controlled study of pecavaptan, a dual V1a/V2 vasopressin receptor antagonist, in patients with acute heart failure: The AVANTI trial.
James E Udelson, Steven R Goldsmith, Daniel Burkhoff, Pablo Colorado, Wilfried Dinh

Eur J Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial.
Javed Butler, Francesco Fioretti, Ciaran J McMullan, Kevin J Anstrom, Irina Barash, James Udelson

Eur Heart J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thresholds of Kidney Function Decline and Congestion Status and Their Relation with Outcomes among Discharged Heart Failure Patients.
Tatsufumi Oka, Hocine Tighiouart, Wendy McCallum, Marcelle Tuttle, Yoshitaka Isaka, James E Udelson

Clin J Am Soc Nephrol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial.
Yogesh N V Reddy, Javed Butler, Kevin J Anstrom, Robert O Blaustein, Marc P Bonaca, James Udelson

Eur J Heart Fail· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics.
Gregg C Fonarow, James E Udelson, Clyde W Yancy

JAMA Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Counts for Worsening Heart Failure Events.
Gregg C Fonarow, Adrian F Hernandez, James E Udelson, Clyde W Yancy

JAMA Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpreting Health Status Measures in Patients With Heart Failure-What Counts.
James E Udelson, Clyde W Yancy, Gregg C Fonarow

JAMA Cardiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiological Pacing for the Prevention and Treatment of Heart Failure: a State-of-the-Art Review.
Margaret Infeld, Jamie A Cyr, Damián Sánchez-Quintana, Christopher Madias, James E Udelson

J Card Fail· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding Treatment in Hospital With Subcutaneous Furosemide for Worsening Heart Failure: A Pilot Study (AT HOME-HF).
Marvin A Konstam, Joseph Massaro, Ravi Dhingra, Mary Walsh, Linda Ordway, James E Udelson

JACC Heart Fail· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies: Substrates and Etiologies.
Annamaria Del Franco, Roberta Ruggieri, Maurizio Pieroni, Michele Ciabatti, Chiara Zocchi, James Udelson

JACC Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction.
Suzanne de Waha, Manesh R Patel, Holger Thiele, James E Udelson, Christopher B Granger

J Am Heart Assoc· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide Trends in Hospitalizations for Atrial Fibrillation and Flutter in the United States before and during the Outbreak of the COVID-19 Pandemic.
Sarah Daoudi, Kevin John, Fadi Chalhoub, Jennifer Chee, Margaret Infeld, James Udelson

J Clin Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
Martin S Maron, Masliza Mahmod, Azlan Helmy Abd Samat, Lubna Choudhury, Daniele Massera, James E Udelson

J Am Coll Cardiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agreement among high-sensitivity cardiac troponin assays and non-invasive testing, clinical outcomes, and quality-of-care outcomes based on the 2020 European Society of Cardiology Guidelines.
Júlia Karády, Thomas Mayrhofer, James L Januzzi, James E Udelson, Jerome L Fleg

Eur Heart J Acute Cardiovasc Care· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW.
Marcelo F Di Carli, Lars C Gormsen, Panithaya Chareonthaitawee, Geoffrey B Johnson, Rob Beanlands, James Udelson

J Nucl Cardiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis